Format

Send to

Choose Destination
Br J Cancer. 2009 Dec 1;101(11):1925-31. doi: 10.1038/sj.bjc.6605378. Epub 2009 Oct 27.

Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Author information

1
Ticino Cancer Registry, Institute of Pathology, Via in Selva 24, Locarno CH-6600, Switzerland. andrea.bordoni@ti.ch

Abstract

BACKGROUND:

Although some clinical-pathological features of breast cancers, such as the incidence of ductal cancer in situ (DCIS) and the diameter of invasive tumours, are sensitive indicators of early detection, comprehensive population-based studies of opportunistic screening are needed.

METHODS:

Cases of DCIS or invasive breast cancer diagnosed in 1996-2007 were identified from the Ticino Cancer Registry (south of Switzerland). Time trends of age-adjusted incidence and mortality, as well as main clinical-pathological features, such as tumour diameter, AJCC stage and histological grade, were analysed.

RESULTS:

A total of 3047 incident cases of female breast cancer were identified. The proportion of DCIS with respect to invasive cases increased from 5.8% in the period 1996-2001 to 6.4% in the period 2002-2007. The median tumour size of invasive cancers decreased from 20 mm in 1996-2001 to 18 mm in 2002-2007 (P<0.0001). An increase in well/moderately differentiated invasive tumours, from 67% in the period 1996-2001 to 73% in 2002-2007 (P<0.001), was detected and resulted in an Annual Percentage Change of incidence of 2.8 (95% confidence interval: 1.3; 4.3).

CONCLUSION:

An opportunistic screening strategy can lead to an improvement of prognostic features at diagnosis, but these features are still less favourable than those achieved by organised screening programmes.

PMID:
19861962
PMCID:
PMC2788260
DOI:
10.1038/sj.bjc.6605378
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center